CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...